CD4 and female reproductive organ cancer: Understanding the underlying factors and mechanisms involved in regulating immune protection by CD4+ T cells from FRT will provide a foundation of information essential for developing therapeutic tools to protect women against gynecological cancers and sexually transmitted infections as women age in the years following menopause.